| Product NDC: | 63323-359 |
| Proprietary Name: | Kanamycin |
| Non Proprietary Name: | KANAMYCIN A SULFATE |
| Active Ingredient(s): | 333 mg/mL & nbsp; KANAMYCIN A SULFATE |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 63323-359 |
| Labeler Name: | APP Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065111 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20030128 |
| Package NDC: | 63323-359-03 |
| Package Description: | 10 VIAL in 1 TRAY (63323-359-03) > 3 mL in 1 VIAL |
| NDC Code | 63323-359-03 |
| Proprietary Name | Kanamycin |
| Package Description | 10 VIAL in 1 TRAY (63323-359-03) > 3 mL in 1 VIAL |
| Product NDC | 63323-359 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | KANAMYCIN A SULFATE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20030128 |
| Marketing Category Name | ANDA |
| Labeler Name | APP Pharmaceuticals, LLC |
| Substance Name | KANAMYCIN A SULFATE |
| Strength Number | 333 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient] |